CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas to moderate panel, "Accessing Capital through Risk-Sharing Models between Early-Stage Companies and Contract Research Organizations" at BIO 2010 in Chicago, IL
News | 05. 05. 2010
